Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey

February 8, 2021 updated by: Snehil Dixit, King Khalid University

Impact of Covid-19 Affliction on Psychological and Mental Health of the College Students: Cross-Sectional Survey

The study aims to study the effects of Novel corona virus (COVID-19) on the psychological and mental health of college going students. Online version of the Event Impact Scale - Revised will be used to filled by the students who got afflicted by the novel corona virus (COVID-19).

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Objective : To study the impact on psychological and mental health of COVID-19 affliction among college going students

Methodology:

Study Design: Cross-sectional Mode of implementation: Online surveys Population : COVID positive College students Inclusion criteria: Students positive to corona tests Exclusion criteria: students negative to corona tests

Study Type

Observational

Enrollment (Anticipated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Saudi Arabia
    • Aseer
      • Abha, Aseer, Saudi Arabia
        • Recruiting
        • King Khalid University
        • Contact:
          • SNEHIL DIXIT, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

College going students

Description

Inclusion Criteria: Students positive for COVID-19 test -

Exclusion Criteria: Students negative for COVID-19 test

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
STUDENTS
COLLEGE STUDENTS WITH POSITIVE COVID-19 TEST
Other: NOT APPLICABLE (NA)
THE INTERVENTION GROUP IS NOT APPLICABLE TO THE CURRENT STUDY DESIGN

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EVENT IMPACT SCALE - REVISED
Time Frame: Within 1 month of the impact of COVID-19
The IES-R is a 22-item self-report measure (for DSM-IV) that assesses subjective distress caused by traumatic events. It is a revised version of the older version, the 15-item IES (Horowitz, Wilner, & Alvarez, 1979). The IES-R contains seven additional items related to the hyperarousal symptoms of PTSD, which were not included in the original IES. Items correspond directly to 14 of the 17 DSM-IV symptoms of PTSD
Within 1 month of the impact of COVID-19

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

King Khalid University

Investigators

  • Principal Investigator: SNEHIL DIXIT, PhD, King Khalid University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 8, 2020

Primary Completion (Anticipated)

March 8, 2021

Study Completion (Anticipated)

March 8, 2021

Study Registration Dates

First Submitted

February 8, 2021

First Submitted That Met QC Criteria

February 8, 2021

First Posted (Actual)

February 9, 2021

Study Record Updates

Last Update Posted (Actual)

February 9, 2021

Last Update Submitted That Met QC Criteria

February 8, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ECM#2020-2501

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The Data cannot be shared without the prior approval of the University

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on NOT APPLICABLE (NA)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe